Advances in non-metastatic castration-resistant prostate cancer
ADT Resistant Non-Metastatic Prostate Cancer (nmCRPC) - 2021 Prostate Cancer Patient Conference
Understanding non metastatic castration resistant prostate cancer with Dr. Hamilton
Living with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): Ron and Laurie’s story
Treating Non-Metastatic Castrate Resistant Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD
Castrate Resistant, Non-Metastatic Prostate Cancer (M0 state) | Prostate Cancer Staging Guide
Risk Stratification in Nonmetastatic Prostate Cancer
Advances in Non-Metastatic Prostate Cancer: Navigating ARPIs and Precision Diagnostics
Morning Medical Update - "Heat Seeking Missile" for Prostate Cancer
Dr. Bradley on Next Steps for Research in Nonmetastatic Prostate Cancer
Challenges in Treating Nonmetastatic Castration-Resistant Prostate Cancer
Docetaxel in Non-metastatic Prostate Cancer
What is New for the Prostate Cancer Patient with Non Metastatic Castration Resistant Prostate Cancer
Understanding Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo Rendon
ROAR study shows promising results for non-metastatic prostate cancer patients with rucaparib
Chemotherapy for NON-METASTATIC PROSTATE CANCER
Clinical Trials in Nonmetastatic Castration-Resistant Prostate Cancer
Identifying and Managing Nonmetastatic Prostate Cancer
FDA Approves Bayer's Nubeqa (Darolutamide) for Non-Metastatic Castration-Resistant Prostate Cancer
When and whether to conduct endocrine therapy in non-metastatic prostate cancer